The Association Between Chemosensitivity and the 10-year Risk of Type 2 Diabetes in Male Patients with Obstructive Sleep Apnea

Overview

Journal Sleep Breath

Publisher Springer

Date 2024 Nov 29

PMID 39612042

Authors

Lixia Wang

Lu Dai

Xiaona Wang

Junwei Guo

Rong Huang

Yi Xiao

Affiliations

Soon will be listed here.

Abstract

Purpose: Obstructive sleep apnea (OSA) is associated with a variety of diseases, including type 2 diabetes (T2D). Chemosensitivity is an important component of the pathophysiological mechanisms of OSA, and it is not only elevated in patients with OSA but also in those with T2D. This study aimed to investigate the association between chemosensitivity and the risk of developing T2D in patients with OSA.

Methods: A total of 135 male participants with OSA and without pre-existing T2D were enrolled in this study. Peripheral chemosensitivity was evaluated using the rebreathing test. Data on demographics, polysomnographic parameters, and clinical characteristics were collected. The QDiabetes-2018 risk calculator was employed to calculate the 10-year T2D risk. The association between peripheral chemosensitivity and 10-year T2D risk was examined using multivariate logistic regression.

Results: A total of 64 participants had moderate-to-high 10-year risk of T2D. In the fully adjusted model, participants situated within the second and fifth quantiles of peripheral chemosensitivity levels demonstrated a higher risk of developing T2D, with OR of 4.87 (95% CI, 1.22-19.43) and 5.26 (95% CI, 1.27-21.68) respectively. However, across varying levels of peripheral chemosensitivity, no significant difference in the 10-year T2D risk was observed among different severities of OSA.

Conclusion: Higher peripheral chemosensitivity was associated with an increased 10-year T2D risk, as calculated using a risk calculator based on clinical variables. For outcomes that reflect a moderate-to-high 10-year risk of T2D, the severity of OSA did not significantly affect the risk, irrespective of whether patients exhibited relatively low or high chemosensitivity.

References

Cunha-Guimaraes J, Guarino M, Timoteo A, Caires I, Sacramento J, Ribeiro M . Carotid body chemosensitivity: early biomarker of dysmetabolism in humans. Eur J Endocrinol. 2020; 182(6):549-557. DOI: 10.1530/EJE-19-0976. View

Langenberg C, Lotta L . Genomic insights into the causes of type 2 diabetes. Lancet. 2018; 391(10138):2463-2474. DOI: 10.1016/S0140-6736(18)31132-2. View

Malhotra A, Ayappa I, Ayas N, Collop N, Kirsch D, McArdle N . Metrics of sleep apnea severity: beyond the apnea-hypopnea index. Sleep. 2021; 44(7). PMC: 8271129. DOI: 10.1093/sleep/zsab030. View

de Araujo E, Guimaraes K, Magnani M, Cruz J, Vidal H, Braga V . Maternal dyslipidemia during pregnancy and lactation increases blood pressure and disrupts cardiorespiratory and glucose hemostasis in female rat offspring. Appl Physiol Nutr Metab. 2019; 44(9):925-936. DOI: 10.1139/apnm-2018-0756. View

Chen L, Magliano D, Balkau B, Colagiuri S, Zimmet P, Tonkin A . AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust. 2010; 192(4):197-202. DOI: 10.5694/j.1326-5377.2010.tb03507.x. View

Benjafield A, Ayas N, Eastwood P, Heinzer R, Ip M, Morrell M . Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019; 7(8):687-698. PMC: 7007763. DOI: 10.1016/S2213-2600(19)30198-5. View

Ronksley P, Hemmelgarn B, Heitman S, Hanly P, Faris P, Quan H . Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax. 2009; 64(10):834-9. DOI: 10.1136/thx.2009.115105. View

Celen Y, Hedner J, Carlson J, Peker Y . Impact of gender on incident diabetes mellitus in obstructive sleep apnea: a 16-year follow-up. J Clin Sleep Med. 2010; 6(3):244-50. PMC: 2883035. View

Xu P, Hui C, Lui M, Lam D, Fong D, Ip M . Incident Type 2 Diabetes in OSA and Effect of CPAP Treatment: A Retrospective Clinic Cohort Study. Chest. 2019; 156(4):743-753. DOI: 10.1016/j.chest.2019.04.130. View

10.

Gloyn A, Drucker D . Precision medicine in the management of type 2 diabetes. Lancet Diabetes Endocrinol. 2018; 6(11):891-900. DOI: 10.1016/S2213-8587(18)30052-4. View

11.

Kengne A, Beulens J, Peelen L, Moons K, van der Schouw Y, Schulze M . Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol. 2014; 2(1):19-29. DOI: 10.1016/S2213-8587(13)70103-7. View

12.

Fredheim J, Rollheim J, Omland T, Hofso D, Roislien J, Vegsgaard K . Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study. Cardiovasc Diabetol. 2011; 10:84. PMC: 3206416. DOI: 10.1186/1475-2840-10-84. View

13.

Schmidt M, Duncan B, Bang H, Pankow J, Ballantyne C, Golden S . Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care. 2005; 28(8):2013-8. DOI: 10.2337/diacare.28.8.2013. View

14.

Powell F . Measuring the respiratory chemoreflexes in humans by J. Duffin. Respir Physiol Neurobiol. 2012; 181(1):44-5. DOI: 10.1016/j.resp.2012.01.007. View

15.

Hruby A, Guasch-Ferre M, Bhupathiraju S, Manson J, Willett W, McKeown N . Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts. Diabetes Care. 2017; 40(12):1695-1702. PMC: 5711333. DOI: 10.2337/dc17-1143. View

16.

Zhang M, Buttigieg J, Nurse C . Neurotransmitter mechanisms mediating low-glucose signalling in cocultures and fresh tissue slices of rat carotid body. J Physiol. 2006; 578(Pt 3):735-50. PMC: 2151341. DOI: 10.1113/jphysiol.2006.121871. View

17.

Eckert D, White D, Jordan A, Malhotra A, Wellman A . Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med. 2013; 188(8):996-1004. PMC: 3826282. DOI: 10.1164/rccm.201303-0448OC. View

18.

Edwards B, Eckert D, McSharry D, Sands S, Desai A, Kehlmann G . Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2014; 190(11):1293-300. PMC: 4315811. DOI: 10.1164/rccm.201404-0718OC. View

19.

Tamura A, Kawano Y, Watanabe T, Kadota J . Relationship between the severity of obstructive sleep apnea and impaired glucose metabolism in patients with obstructive sleep apnea. Respir Med. 2008; 102(10):1412-6. DOI: 10.1016/j.rmed.2008.04.020. View

20.

Samson P, Casey K, Knepler J, Panos R . Clinical characteristics, comorbidities, and response to treatment of veterans with obstructive sleep apnea, Cincinnati Veterans Affairs Medical Center, 2005-2007. Prev Chronic Dis. 2012; 9:E46. PMC: 3337849. DOI: 10.5888/pcd9.110117. View